Motivational Enhancement for Spanish Speaking Individuals - 1

This study has been completed.
Sponsor:
Collaborator:
University of Miami
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00078169
First received: February 19, 2004
Last updated: April 13, 2010
Last verified: April 2010
  Purpose

The purpose of this study is to compare a three-session Spanish version of Motivational Enhancement Therapy (MET) to standard treatment to see how well MET engages and retains Spanish-speaking clients in outpatient substance abuse treatment.


Condition Intervention Phase
Substance-Related Disorders
Behavioral: Behavior Therapy
Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Motivational Enhancement for Spanish Speaking Individuals

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Treatment retention, drug and alcohol abstinence

Estimated Enrollment: 463
Study Start Date: November 2003
Study Completion Date: October 2005
Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

All subjects included unless medical/psychiatrically unstable

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00078169

Locations
United States, Colorado
Island Grove RTC
Greeley, Colorado, United States, 80631
United States, Florida
Miami Behavioral Health
Miami, Florida, United States, 33161
United States, New Mexico
Counseling & Psychotherapy Institute
Albuquerque, New Mexico, United States, 87194
The Life Link
Santa Fe, New Mexico, United States, 87505
United States, New York
Narco Freedom (Bridge Plaza)
Long Island City, New York, United States, 11101
United States, Oregon
Changepoint, Inc.
Portland, Oregon, United States, 97402
Changepoint - Cedar Hills Blvd
Portland, Oregon, United States, 97292
Sponsors and Collaborators
Yale University
University of Miami
Investigators
Principal Investigator: Kathleen Carroll, Ph.D. Yale University
  More Information

No publications provided

Responsible Party: Kathleen Carroll, Ph.D., Yale University School of Medicine
ClinicalTrials.gov Identifier: NCT00078169     History of Changes
Other Study ID Numbers: NIDA-CTN-0021-1
Study First Received: February 19, 2004
Last Updated: April 13, 2010
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 22, 2014